<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the use of <z:chebi fb="7" ids="33372">neodymium</z:chebi>:<z:chebi fb="2" ids="33331">yttrium</z:chebi>-<z:chebi fb="6" ids="28984">aluminum</z:chebi>-garnet (Nd:YAG) laser ablation to treat high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and intramucosal esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> associated with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> in a patient who refused surgery </plain></SENT>
<SENT sid="1" pm="."><plain>Throughout laser therapy, the patient received <z:chebi fb="14" ids="7772">omeprazole</z:chebi> 40 mg/day </plain></SENT>
<SENT sid="2" pm="."><plain>After 1 1/2 yr, five laser treatments totaling 22,055 J given over a period of 13 months achieved squamous reepithelialization and absence of <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> in the first area in which <z:mp ids='MP_0002038'>carcinoma</z:mp> was diagnosed </plain></SENT>
<SENT sid="3" pm="."><plain>Squamous reepithelialization was maintained 1 yr later, confirming recent reports that photoablation plus <z:chebi fb="14" ids="7772">omeprazole</z:chebi> can achieve regression of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>During the last year of follow-up, a second contiguous area discovered to contain <z:mp ids='MP_0002038'>carcinoma</z:mp> was treated three times by photoablation, with a total of 13,164 J; biopsy showed only low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in this area after two laser treatments totaling 8,108 J </plain></SENT>
<SENT sid="5" pm="."><plain>No complications were seen during or after any of the laser sessions, and the patient remained asymptomatic 2 1/2 yr after the first photoablation and 3 yr after presentation </plain></SENT>
</text></document>